Moleculera Labs and General Genomics Form Strategic Alliance to Utilize Proprietary AI to Provide Personalized Medicine for Autoimmune Neuropsychiatric Disorders
By AIT News Desk On Jul 26, 2022 Moleculera Labs, Inc. (Moleculera) and General Genomics, Inc. (GGI) announce the formation of a strategic alliance between the two companies. GGI will bring the power of multiple patent-pending healthcare machine learning (ML) and artificial intelligence (AI) innovations to direct individualized healthcare via their Curo46 Engine. Moleculera will […]
